• Evertrace
  • Posts
  • Launches by Evertrace - Week 49

Launches by Evertrace - Week 49

Preview the power of AI-powered founder detection

Welcome to Launches by Evertrace!

Get a sneak peek of what our platform can do with this data-driven newsletter, crafted to help investors discover new opportunities. Enjoy this week’s edition - we’re excited to have you with us!

Heads up! The data in the Launches by Evertrace newsletter are intentionally delayed to give our customers a strategic advantage. Access real-time signals by requesting a free trial.

New Incorporations

Evertrace flags thousands of fresh company incorporations each month. Here’s a snapshot of the new entities found in local trade registries:

Mistral Compute 4
Paris, France· 30 November 2025

Founder: Arthur Mensch

Description: Third-party maintenance of IT systems and applications

GRIVE GmbH
Bern, Switzerland· 27 November 2025

Founder: Martin Seiler

Description: Provision of services in the field of information technology, in particular the development of software and the sale of related products

FRACTAL BRAIN LTD
London, United Kingdom· 24 November 2025

Description: The company provides business and domestic software development along with IT facilities management, other information technology services, and data processing and hosting

Newly published patents

Evertrace identifies newly published patents with breakthrough potential. Explore recent standouts:

Dual-Fluid Electrodes
Aachen, Germany
Inventor: Matthias Wessling

Description: Electrode arrangement for an electrochemical cell with two same-polarity electrodes in separate chambers, each contacted by a different fluid and configured to perform different electrochemical reactions independently

Gas Cooling System
Nürnberg, Deutschland
Inventor: Volker Münch

Description: A system for stepwise cooling of very hot, CO₂-containing gases using temperature-optimized heat pipes and Peltier elements down to about 50°C, combined with an absorber/desorber unit and a mobile or stationary plant for efficient CO₂ capture

RIPK1 Disease Treatment
Munich, Germany
Inventor: Felix Lauffer

Description: Provides methods of treating receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitors with eclitasertib

Get real-time signals and deep intelligence by requesting access to Evertrace.